EMERYVILLE, Calif.--(BUSINESS WIRE)--AllCells, LLC, a leading global provider of hematology and immunology based primary cells and related services for drug discovery, toxicology, stem cell research, and other life science applications today announced the appointment of its first Scientific Advisory Board (SAB). The new SAB members include:
Linzhao Cheng, PhD - Professor of Medicine and a founding member of the Stem Cell Program in the Johns Hopkins Institute for Cell Engineering, JHU School of Medicine (JHUSOM), Baltimore, MD. He is also the Associate Director for Basic Research, Division of Hematology, and a faculty member in PhD Training Programs in Cellular & Molecular Medicine, Human Genetics and Immunology in JHUSOM. Dr. Cheng will serve as Chairman of AllCells’ SAB.
